Risk of heart failure may be lower with celecoxib than with other NSAIDBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7452.1338-a (Published 03 June 2004) Cite this as: BMJ 2004;328:1338
- Barbara Kermode-Scott
The anti-inflammatory cyclo-oxygenase-2 (COX 2) inhibitor celecoxib may be associated with a lower risk of congestive heart failure in the elderly than other non-steroidal anti-inflammatory drugs (NSAIDs), a large new Canadian study has found.
This study, published online on 29 May in the Lancet (http://www.thelancet.com/), was funded by the Canadian Institutes of Health Research.
“Our findings suggest significant differences between non-selective NSAIDs and individual COX 2 inhibitors with respect to risk of admission for congestive heart failure,” said the study's lead author, Professor Muhammad Mamdani, assistant professor in clinical epidemiology and healthcare research, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial